InsiderTrades.com logo
Grab This Altcoin Before Trump's Crypto Announcement
From Crypto 101 Media   |   Ad
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
Click here to check it out now
Joan W. Miller net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Joan Miller Biography and Net Worth

Director of Aptinyx
Joan Miller has a Bachelor of Science in Biology from Massachusetts Institute of Technology in 1980 and a Doctor of Medicine from Harvard Medical School in 1985.

How do I contact Joan W. Miller?

The corporate mailing address for Ms. Miller and other Aptinyx executives is 909 DAVIS STREET SUITE 600, EVANSTON IL, 60201. Aptinyx can also be reached via phone at (847) 871-0377 and via email at [email protected]. Learn More on Joan W. Miller's contact information.

Has Joan W. Miller been buying or selling shares of Aptinyx?

Joan W. Miller has not been actively trading shares of Aptinyx during the last quarter. Most recently, on Thursday, January 13th, Joan W. Miller bought 17,700 shares of Aptinyx stock. The stock was acquired at an average cost of $2.83 per share, with a total value of $50,091.00. Learn More on Joan W. Miller's trading history.

Who are Aptinyx's active insiders?

Aptinyx's insider roster includes Robert Hombach (Director), Ashish Khanna (CFO), Joan Miller (Director), and Norbert Riedel (CEO). Learn More on Aptinyx's active insiders.

Joan W. Miller Insider Trading History at Aptinyx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/13/2022Buy17,700$2.83$50,091.00View SEC Filing Icon  
See Full Table

Joan W. Miller Buying and Selling Activity at Aptinyx

This chart shows Joan W Miller's buying and selling at Aptinyx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aptinyx Company Overview

Aptinyx logo
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Its lead product candidate NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat opioid use disorder, or OUD; and in preclinical trial for the treatment of alcohol use disorder, or AUD. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.
Read More

Today's Range

Now: $0.10
Low: $0.09
High: $0.10

50 Day Range

MA: $0.08
Low: $0.06
High: $0.10

2 Week Range

Now: $0.10
Low: $0.01
High: $0.72

Volume

231,100 shs

Average Volume

1,317,051 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27
Grab This Altcoin Before Trump's Crypto Announcement
From Crypto 101 Media   |   Ad
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
Click here to check it out now